₹1910.0
-0.26% today
· 30d +8.52%
as of 2026-11-09
Price · Daily Candles
“Sun Pharma's profits surge as DIIs increase stake amid strong operational performance.”
Sun Pharma reported a 16.07% YoY net profit growth and 13.49% YoY revenue increase in Q4 2025, driven by a 23.53% rise in operating profit. DIIs have shown confidence, increasing their stake by 0.29% QoQ to 21.11%, while FIIs reduced theirs by 0.19% to 15.93%. The stock currently trades at a P/E of 38.46, with a strong growth outlook indicated by ML predictions scoring above 0.7 for sales and FCF.
BULL CASE
+Q4 2025 net profit soared by 16.07% YoY and revenue by 13.49% YoY, reflecting strong operational performance.
+Operating profit for Q4 2025 jumped by 23.53% YoY, with OPM expanding by 2.69%.
+DIIs increased their shareholding by 0.29% QoQ to 21.11% in Q4 2026, indicating domestic conviction.
+The company's 3-year net profit CAGR stands at 47.9%, showcasing historical profitability gains.
+ML models predict strong growth for sales (0.742-0.854 rank) and FCF (0.721-0.747 rank) in the immediate future.
BEAR CASE
−Despite growth, the stock trades at a TTM P/E of 38.46, higher than peers like CIPLA (29.52) and DRREDDY (19.55).
−FIIs reduced their stake by 0.19% QoQ to 15.93% in Q4 2026.
−The stock is trading at ₹1842.5, close to its 52-week high of ₹1916.6, with a -3.87% proximity to the high.
−While 3-year net profit CAGR is 47.9%, the 5-year CAGR is lower at 21.32%.
⟳ What Changed
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹15300 Cr
+10.46% YoY
NET PROFIT
₹2901 Cr
+26.53% YoY
OPM
32.09%
-1.21pp YoY
EPS
₹12.1
PE 38.46
Intrinsic value · DCF ₹3706.17 · Margin of safety +94.0% (undervalued) · FCF yield 1.92%
◇ Sector Position
Sun Pharma's P/E of 38.46 is elevated compared to industry peers like Dr. Reddy's (19.55) and Cipla (29.52), while its ROCE of 20.0% lags behind the latter's 25.09-27.63% range.
PEERPEROCE %
SUNPHARMA38.4620.0
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒
69
SCORE / 100
Overall
6-axis composite of the sections below.
Performance
STRONG
75
Valuation
FAIR
40
Growth
STEADY
63
Profitability
HIGH
92
Technicals
NEUTRAL
53
Risk
LOW
90
Key Stats
TTM PE
38.46
P/B
5.67
52W HIGH
₹2046.9
OFF HIGH
-6.69%
DIV YIELD
0.9%
MKT CAP
₹457850 Cr
◉ Active Signals
MACDBullish21.6444
RSI(14)Bearish70.75
Street Consensus
34 analysts₹2041.74
mean target
Low ₹1650.0Now ₹1910.0High ₹2528.0
⧉ Strategy Fit 🔒